South Korean Firms to Inject 10 Trillion Won into Biotechnology by 2023
South Korean biotech companies, including Celltrion and Samsung Biologics, would jointly invest a total of 10 trillion won ($9.03 billion) ...
South Korean biotech companies, including Celltrion and Samsung Biologics, would jointly invest a total of 10 trillion won ($9.03 billion) ...
Samsung Biologics announced on Tuesday that it successfully produced the first batch of Eli Lilly’s COVID-19 antibody treatment. This came ...
Samsung Biologics Co. on Friday said that it signed an eight-year contract manufacturing organization (CMO) deal valued at 287 billion ...
Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...
Samsung Biologics announced on Tuesday that it signed a contract with Aprinoia Therapeutics to develop the Taiwan-based biotech firm's Alzheimer's ...
CEO of Samsung Biologics Kim Tae-han said on Wednesday that he expects the company to take on contract deals for ...
606 total views, 3 views today
460 total views, 4 views today
439 total views, 2 views today
336 total views, 4 views today
498 total views, 3 views today
427 total views, 6 views today
385 total views, 6 views today
346 total views, 3 views today
353 total views, 9 views today
340 total views, 3 views today
Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : press@koreatechtoday.com |
Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : press@koreatechtoday.com |